520 related articles for article (PubMed ID: 27058328)
1. [Comparison of the CMV antigenemia test and CMV-DNA PCR results in solid organ transplant recipients].
Özkarata E; Özbek ÖA; Avkan Oğuz V; Sayıner AA
Mikrobiyol Bul; 2016 Jan; 50(1):44-52. PubMed ID: 27058328
[TBL] [Abstract][Full Text] [Related]
2. Differences between the quantitative antigenemia assay and the cobas amplicor monitor quantitative PCR assay for detecting CMV viraemia in bone marrow and solid organ transplant patients.
Flexman J; Kay I; Fonte R; Herrmann R; Gabbay E; Palladino S
J Med Virol; 2001 Jul; 64(3):275-82. PubMed ID: 11424115
[TBL] [Abstract][Full Text] [Related]
3. Analysis of a quantitative PCR assay for CMV infection in liver transplant recipients: an intent to find the optimal cut-off value.
Martín-Dávila P; Fortún J; Gutiérrez C; Martí-Belda P; Candelas A; Honrubia A; Barcena R; Martínez A; Puente A; de Vicente E; Moreno S
J Clin Virol; 2005 Jun; 33(2):138-44. PubMed ID: 15911429
[TBL] [Abstract][Full Text] [Related]
4. Comparison of quantitative PCR and antigenemia in cytomegalovirus infection in renal transplant recipients.
Bordils A; Plumed JS; Ramos D; Beneyto I; Mascarós V; Molina JM; Cordoba J; García J; Crúz JM
Transplant Proc; 2005 Nov; 37(9):3756-9. PubMed ID: 16386529
[TBL] [Abstract][Full Text] [Related]
5. CMV antigenemia and quantitative viral load assessments in hematopoietic stem cell transplant recipients.
Cardeñoso L; Pinsky BA; Lautenschlager I; Aslam S; Cobb B; Vilchez RA; Hirsch HH
J Clin Virol; 2013 Feb; 56(2):108-12. PubMed ID: 23146665
[TBL] [Abstract][Full Text] [Related]
6. [Investigation of cytomegalovirus positivity in the peripheral blood samples of risky patients by shell-vial cell culture, antigenemia test and real-time polymerase chain reaction].
Gökahmetoğlu S; Yağmur G; Mutlu Sarıgüzel F; Deniz E
Mikrobiyol Bul; 2011 Apr; 45(2):288-95. PubMed ID: 21644072
[TBL] [Abstract][Full Text] [Related]
7. Cytomegalovirus (CMV) DNA amplification from plasma compared with CMV pp65 antigen (ppUL83) detection in leukocytes for early diagnosis of symptomatic CMV infection in kidney transplant patients.
Wirgart BZ; Claesson K; Eriksson BM; Brundin M; Tufveson G; Tötterman T; Grillner L
Clin Diagn Virol; 1996 Nov; 7(2):99-110. PubMed ID: 9137866
[TBL] [Abstract][Full Text] [Related]
8. Assessment of CMV load in solid organ transplant recipients by pp65 antigenemia and real-time quantitative DNA PCR assay: correlation with pp67 RNA detection.
Mengoli C; Cusinato R; Biasolo MA; Cesaro S; Parolin C; Palù G
J Med Virol; 2004 Sep; 74(1):78-84. PubMed ID: 15258972
[TBL] [Abstract][Full Text] [Related]
9. Comparison of two quantitative CMV PCR tests, Cobas Amplicor CMV Monitor and TaqMan assay, and pp65-antigenemia assay in the determination of viral loads from peripheral blood of organ transplant patients.
Piiparinen H; Höckerstedt K; Grönhagen-Riska C; Lautenschlager I
J Clin Virol; 2004 Jul; 30(3):258-66. PubMed ID: 15135746
[TBL] [Abstract][Full Text] [Related]
10. Diagnosing cytomegalovirus disease in CMV seropositive renal allograft recipients: a comparison between the detection of CMV DNAemia by polymerase chain reaction and antigenemia by CMV pp65 assay.
Lo CY; Ho KN; Yuen KY; Lui SL; Li FK; Chan TM; Lo WK; Cheng IK
Clin Transplant; 1997 Aug; 11(4):286-93. PubMed ID: 9267717
[TBL] [Abstract][Full Text] [Related]
11. Optimization of quantitative detection of cytomegalovirus DNA in plasma by real-time PCR.
Boeckh M; Huang M; Ferrenberg J; Stevens-Ayers T; Stensland L; Nichols WG; Corey L
J Clin Microbiol; 2004 Mar; 42(3):1142-8. PubMed ID: 15004066
[TBL] [Abstract][Full Text] [Related]
12. Comparison of cytomegalovirus viral load measure by real-time PCR with pp65 antigenemia for the diagnosis of cytomegalovirus disease in solid organ transplant patients.
Hernando S; Folgueira L; Lumbreras C; San Juan R; Maldonado S; Prieto C; Babiano MJ; Delgado J; Andres A; Moreno E; Aguado JM; Otero JR
Transplant Proc; 2005 Nov; 37(9):4094-6. PubMed ID: 16386635
[TBL] [Abstract][Full Text] [Related]
13. Quantitation of cytomegalovirus DNA by real-time polymerase chain reaction in peripheral blood specimens of patients with solid organ transplants: comparison with end-point PCR and pp65 antigen test.
Allice T; Enrietto M; Pittaluga F; Varetto S; Franchello A; Marchiaro G; Ghisetti V
J Med Virol; 2006 Jul; 78(7):915-22. PubMed ID: 16721848
[TBL] [Abstract][Full Text] [Related]
14. Monitoring low cytomegalovirus viremia in transplanted patients by a real-time PCR on plasma.
Schvoerer E; Henriot S; Zachary P; Freitag R; Fuchs A; Fritsch S; Risch S; Meyer N; Caillard S; Lioure B; Stoll-Keller F
J Med Virol; 2005 May; 76(1):76-81. PubMed ID: 15778970
[TBL] [Abstract][Full Text] [Related]
15. Analysis of cytomegalovirus (CMV) viremia using the pp65 antigenemia assay, the amplicor CMV test, and a semi-quantitative polymerase chain reaction test after allogeneic marrow transplantation.
Ksouri H; Eljed H; Greco A; Lakhal A; Torjman L; Abdelkefi A; Ben Othmen T; Ladeb S; Slim A; Zouari B; Abdeladhim A; Ben Hassen A
Transpl Infect Dis; 2007 Mar; 9(1):16-21. PubMed ID: 17313466
[TBL] [Abstract][Full Text] [Related]
16. Cytomegalovirus diagnosis in renal and bone marrow transplant recipients: the impact of molecular assays.
Halwachs-Baumann G; Wilders-Truschnig M; Enzinger G; Eibl M; Linkesch W; Dornbusch HJ; Santner BI; Marth E; Kessler HH
J Clin Virol; 2001 Jan; 20(1-2):49-57. PubMed ID: 11163583
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of CMV viral load using TaqMan CMV quantitative PCR and comparison with CMV antigenemia in heart and lung transplant recipients.
Guiver M; Fox AJ; Mutton K; Mogulkoc N; Egan J
Transplantation; 2001 Jun; 71(11):1609-15. PubMed ID: 11435973
[TBL] [Abstract][Full Text] [Related]
18. Quantification of cytomegalovirus DNA by a fully automated real-time PCR for early diagnosis and monitoring of active viral infection in solid organ transplant recipients.
Boaretti M; Sorrentino A; Zantedeschi C; Forni A; Boschiero L; Fontana R
J Clin Virol; 2013 Feb; 56(2):124-8. PubMed ID: 23182772
[TBL] [Abstract][Full Text] [Related]
19. Clinically-based determination of safe DNAemia cutoff levels for preemptive therapy or human cytomegalovirus infections in solid organ and hematopoietic stem cell transplant recipients.
Lilleri D; Baldanti F; Gatti M; Rovida F; Dossena L; De Grazia S; Torsellini M; Gerna G
J Med Virol; 2004 Jul; 73(3):412-8. PubMed ID: 15170637
[TBL] [Abstract][Full Text] [Related]
20. Cytomegalovirus (CMV) Monitoring After Liver Transplantation: Comparison of CMV Pp65 Antigenemia Assay with Real-Time PCR Calibrated to WHO International Standard.
Kamei H; Ito Y; Onishi Y; Suzuki M; Imai H; Kurata N; Hori T; Tainaka T; Uchida H; Ogura Y
Ann Transplant; 2016 Mar; 21():131-6. PubMed ID: 26927444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
